Germany’s Evotec has penned another deal amid a stream of R&D pacts over the past year, this time with PARP player Tesaro.
Major CRO Parexel has teamed up with tech giant Microsoft to create a new cloud tech alliance, all aimed at speeding up drug research.
A year after launching its Japanese business, Clinigen has bought Japan’s largest supplier of unlicensed medicines.
WuXi AppTec buys U.S.-based full-service CRO ResearchPoint Global, tapping the latter's clinical operations in over 60 countries.
OmniComm signed its seventh client in China that uses its phase 1 EDC system TrialOne.
SynteractHCR has seen another change-up as it moves its headquarters to larger digs.
U.K.-based trial services company Ergomed has penned a deal to buy PSR Group BV, a specialist orphan drug CRO, as it adds to its offerings.
Treos Bio has tapped PPD to manage its first-in-human study on its lead cancer vaccine for colorectal cancer.
The new "Vant" added to the Vivek Ramaswamy family, with its aim of improving trials with artificial intelligence, announced its new CEO this week.
Concept Life Sciences has taken two new lab spaces at Alderley Park, adding 55 scientists to sustain its 30% year-over-year growth momentum.